CITADEL ADVISORS LLC: NGNE position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CITADEL ADVISORS LLC on NGNE, newest first. How the timeline and the estimate are built.
CITADEL ADVISORS LLC held 408,982 NGNE shares at 2026-06-30 per its 13F-HR/A filed 2026-09-02.
the latest 13F is the newest step
- period ended2026-06-3013F/A 408,982 sharesChange vs previous 13F +21,951 shares
0.01% of the 13F portfolio, value $12,862,484.
13F-HR/A 0001104659-26-104387 filed by CITADEL ADVISORS LLC
Accepted , ingested - period ended2026-03-3113F 387,031 sharesChange vs previous 13F +22,803 shares
0.01% of the 13F portfolio, value $7,802,545.
13F-HR 0001104659-26-062477 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 364,228 sharesChange vs previous 13F +364,228 shares
0.01% of the 13F portfolio, value $7,503,097.
13F-HR 0001104659-26-016408 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 0 sharesChange vs previous 13F -16,416 shares
13F-HR 0001104659-25-078555 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-03-3113F 16,416 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $192,231.
13F-HR 0000950123-25-005687 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).